Dodge & Cox’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.01B | Buy |
3,826,283
+1,502,198
| +65% | +$789M | 1.13% | 35 |
|
|
2025
Q1 | $1.47B | Buy |
2,324,085
+2,769
| +0.1% | +$1.76M | 0.84% | 46 |
|
|
2024
Q4 | $1.65B | Buy |
2,321,316
+9,381
| +0.4% | +$6.68M | 0.96% | 41 |
|
|
2024
Q3 | $2.43B | Sell |
2,311,935
-3,751
| -0.2% | -$3.94M | 1.37% | 27 |
|
|
2024
Q2 | $2.43B | Sell |
2,315,686
-44,178
| -2% | -$46.4M | 1.46% | 24 |
|
|
2024
Q1 | $2.27B | Sell |
2,359,864
-7,816
| -0.3% | -$7.52M | 1.32% | 29 |
|
|
2023
Q4 | $2.08B | Sell |
2,367,680
-5,318
| -0.2% | -$4.67M | 1.32% | 28 |
|
|
2023
Q3 | $1.95B | Sell |
2,372,998
-21,357
| -0.9% | -$17.6M | 1.32% | 26 |
|
|
2023
Q2 | $1.72B | Buy |
2,394,355
+9,654
| +0.4% | +$6.94M | 1.15% | 28 |
|
|
2023
Q1 | $1.96B | Buy |
2,384,701
+161,642
| +7% | +$133M | 1.34% | 25 |
|
|
2022
Q4 | $1.6B | Sell |
2,223,059
-63,450
| -3% | -$45.8M | 1.1% | 33 |
|
|
2022
Q3 | $1.58B | Buy |
2,286,509
+21,175
| +0.9% | +$14.6M | 1.19% | 31 |
|
|
2022
Q2 | $1.34B | Buy |
2,265,334
+28,271
| +1% | +$16.7M | 0.93% | 44 |
|
|
2022
Q1 | $1.56B | Buy |
2,237,063
+1,957,941
| +701% | +$1.37B | 0.95% | 42 |
|
|
2021
Q4 | $176M | Buy |
+279,122
| New | +$176M | 0.11% | 85 |
|